By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arno Therapeutics 

30 Two Bridges Road
Suite 270
Fairfield  New Jersey  07004  U.S.A.
Phone: 862-703-7170 Fax: 973-227-5759


Company News
Arno Therapeutics To Present At 17th Annual Rodman & Renshaw Conference 9/1/2015 12:34:25 PM
Arno Therapeutics Receives Authorization to Proceed With Modified Phase I/II Trial Evaluating Onapristone In Prostate Cancer 8/18/2015 7:53:41 AM
Arno Therapeutics Reports Second Quarter 2015 Financial Results And Business Update 8/17/2015 6:48:37 AM
Arno Therapeutics Announces Issuance Of First Onapristone Patent 6/4/2015 7:49:31 AM
Arno Therapeutics Announces Cooperative Research And Development Agreement With US Army Medical Research Institute Of Infectious Diseases To Test Antiviral Activity Of AR-12 6/3/2015 7:18:00 AM
Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online In Antiviral Research 5/29/2015 8:50:25 AM
Arno Therapeutics Reports First Quarter 2015 Financial And Business Update 5/17/2015 4:47:22 PM
Arno Therapeutics Announces Preclinical Data Demonstrating Broad-Spectrum Antiviral Activity For AR-12 5/15/2015 7:13:37 AM
Arno Therapeutics Announces Data Validating Continued Onapristone And Companion Diagnostic Development At ASCO Annual Meeting 2015 5/14/2015 1:20:40 PM
Arno Therapeutics Receives USPTO Notice Of Allowance For Two Important Patents Covering Lead Compound Onapristone 5/7/2015 7:42:07 AM